ResMed Given Consensus Recommendation of “Hold” by Analysts (NYSE:RMD)
ResMed (NYSE:RMD) has earned an average recommendation of “Hold” from the fourteen brokerages that are currently covering the stock, AnalystRatingsNetwork.com reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $45.90.
A number of research firms have recently commented on RMD. Analysts at Zacks reiterated a “neutral” rating on shares of ResMed in a research note on Friday, August 22nd. They now have a $54.00 price target on the stock. Separately, analysts at Piper Jaffray cut their price target on shares of ResMed from $55.00 to $53.00 in a research note on Friday, August 1st. Finally, analysts at Canaccord Genuity cut their price target on shares of ResMed from $43.00 to $39.00 in a research note on Friday, August 1st.
Shares of ResMed (NYSE:RMD) opened at 52.89 on Wednesday. ResMed has a 52 week low of $41.52 and a 52 week high of $57.34. The stock has a 50-day moving average of $50.90 and a 200-day moving average of $48.77. The company has a market cap of $7.413 billion and a P/E ratio of 22.13.
ResMed (NYSE:RMD) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.64 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.66 by $0.02. The company had revenue of $415.20 million for the quarter, compared to the consensus estimate of $433.42 million. During the same quarter in the prior year, the company posted $0.62 earnings per share. The company’s quarterly revenue was up .1% on a year-over-year basis. On average, analysts predict that ResMed will post $2.59 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Thursday, September 18th. Shareholders of record on Thursday, August 21st will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 2.12%. The ex-dividend date is Tuesday, August 19th. This is a positive change from ResMed’s previous quarterly dividend of $0.25.
ResMed Inc, (NYSE:RMD) is a holding company for the ResMed Group.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.